Table 3 Adverse effects, reported and observed, in women using AAS or clenbuterol
From: Recruitment to doping and help-seeking behavior of eight female AAS users
Subject | Self-reported adverse effect | Cholesterol mmol/L | HDL/LDL mmol/L | HB g/L |
|---|---|---|---|---|
K1 | Clitoral enlargement, voice change, body hair growth, menstrual disorders | 4.2 | 0.7/3.3 | 135 |
K2 | Tachycardia, depression | 3.2 | 1.2/1.6 | 125 |
K3 | Tachycardia, depression, mood changes, edema | 5.9 | 1.4/4 | NA |
K4 | Clitoral enlargement, voice change, menstrual disorders, acne, body hair growth | 3.8 | 0.6/3 | 154 |
K5 | Enlarged clitoris, voice change, body hair growth, acne, menstrual disorder | 3.6 | 1.5/1.9 | 134 |
K6 | Clitoral enlargement, voice change, menstrual disorders, body hair growth, aggressiveness, acne, memory disturbance, stretch marks, tremor, tachycardia, depression | 3.9 | 1.2/2.1 | 134 |
K7 | Clitoral enlargement, voice change, menstrual disorders, acne, mood changes, depression, lost hair head | 4.3 | 1.9/2.0 | 134 |
K8 | Clitoral enlargement, voice change, mood swings, stretch marks, reduced breast | 3.2 | 0.7/2.2 | 128 |